Australian consensus guidelines for the safe handling of monoclonal antibodies for cancer treatment by healthcare personnel-Reference-Cited by-同舟云学术

Australian consensus guidelines for the safe handling of monoclonal antibodies for cancer treatment by healthcare personnel

Published:2014-10 Issue:10 Volume:44 Page:1018-1026
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Alexander M.¹,King J.²,Bajel A.³,Doecke C.⁴⁵,Fox P.⁶⁷,Lingaratnam S.¹,Mellor J. D.¹⁸,Nicholson L.⁹,Roos I.¹⁰,Saunders T.¹¹¹,Wilkes J.¹²¹³,Zielinski R.⁶⁷,Byrne J.¹⁴,MacMillan K.²,Mollo A.²,Kirsa S.¹,Green M.¹⁵

Affiliation:

1. Pharmacy Department; Peter MacCallum Cancer Centre; Melbourne Victoria Australia

2. Pharmacy Department; Western Health; Melbourne Victoria Australia

3. Department of Haematology; Royal Melbourne Hospital; Melbourne Victoria Australia

4. Pharmacy Department; Royal Adelaide Hospital; Adelaide South Australia Australia

5. School of Pharmacy and Medical Sciences; University of South Australia; Adelaide South Australia Australia

6. Department of Medical Oncology; Central West Cancer Service; Orange New South Wales Australia

7. School of Medicine; University of Western Sydney; Sydney New South Wales Australia

8. Roche Pty Ltd; Sydney New South Wales Australia

9. Oncology/Haematology Services; Royal Hobart Hospital; Hobart Tasmania Australia

10. Youth Research Centre; The University of Melbourne; Melbourne Victoria Australia

11. Cancer Nurses Society of Australia; National Executive Committee; Melbourne Victoria Australia

12. View Health Pty Ltd; Perth Western Australia Australia

13. Chemo@home Pty Ltd; Perth Western Australia Australia

14. Western and Central Melbourne Integrated Cancer Service (WCMICS); Melbourne Victoria Australia

15. Cancer Services; Western Health; Melbourne Victoria Australia

Funder

Western and Central Melbourne Integrated Cancer Service (WCMICS)

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.12564/fullpdf

Reference43 articles.

1. Developing evidence-based clinical practice guidelines in hospitals in Australia, Indonesia, Malaysia, the Philippines and Thailand: values, requirements and barriers;Turner;BMC Health Serv Res,2009

2. A survey of manufacturing and handling practices for monoclonal antibodies (MABs) by pharmacy, nursing and medical personnel;Alexander;J Oncol Pharm Pract,2014

3. A review of the evidence for occupational exposure risks to novel anticancer agents - a focus on monoclonal antibodies;King;J Oncol Pharm Pract,2014

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influences Shaping Clinicians’ Monoclonal Antibody and Immune Checkpoint Inhibitor Preparation and Administration Management Practices: A Systematic Review;Seminars in Oncology Nursing;2024-04

2. Use of Closed System Transfer Devices (CSTDs) with Protein-Based Therapeutic Drugs—A Non-Solution for a Non-Problem?;Journal of Pharmaceutical Sciences;2023-11

3. Developing a flowchart to evaluate the use of Closed System Drug-Transfer Devices with monoclonal antibodies: Focus on the clinical trial setting;Journal of Oncology Pharmacy Practice;2023-09-08

4. Clinical Oncology Society of Australia Position Statement: 2022 update to the safe handling of monoclonal antibodies in healthcare settings;Asia-Pacific Journal of Clinical Oncology;2023-03-10

5. Management guidelines for preventing exposure to antineoplastics;Chinese Journal of Cancer Research;2023